Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Inari Medical Inc (NQ: NARI )

49.66 -0.09 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inari Medical Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Inari Medical to Announce First Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
What 8 Analyst Ratings Have To Say About Inari Medical
Via Benzinga
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
From Inari Medical, Inc.
Via GlobeNewswire
Forecasting The Future: 7 Analyst Projections For Inari Medical
Via Benzinga
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
From Inari Medical, Inc.
Via GlobeNewswire
Market Cap Game Show: Andy Cross vs. Bill Mann
Join the "Rule Breaker Investing" fun. 
Via The Motley Fool
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox &amp; Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
NEW YORK, NY - (NewMediaWire) - March 20, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox &amp; Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
NEW YORK, NY - (NewMediaWire) - March 19, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox &amp; Kilsheimer LLP
NEW YORK, NY - (NewMediaWire) - March 18, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox &amp; Kilsheimer LLP
NEW YORK, NY - (NewMediaWire) - March 17, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical Following Inari Medical's Disclosure of a DOJ Investigation Related to Anti-Kickback Laws
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox &amp; Kilsheimer LLP Continues its Investigation of Inari Medical Following Inari Medical's Disclosure of a DOJ Investigation Related to Anti-Kickback Laws
NEW YORK, NY - (NewMediaWire) - March 16, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox &amp; Kilsheimer LLP Investigates Inari Medical in Connection with Inari Medical's Receipt of a Civil Investigative Demand from the U.S. Department of Justice
NEW YORK, NY - (NewMediaWire) - March 15, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical in Connection with Inari Medical's Receipt of a Civil Investigative Demand from the U.S. Department of Justice
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical for Potential Securities Law Violations and Encourages Investors to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox &amp; Kilsheimer LLP Investigates Inari Medical for Potential Securities Law Violations and Encourages Investors to Contact the Firm
NEW YORK, NY - (NewMediaWire) - March 14, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
Bragar Eagel & Squire, P.C. Is Investigating SSR, Inari Medical, and Entravision and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
Rates of Post Thrombotic Syndrome at two years were excellent and significantly lower than rates reported in historical Deep Vein Thrombosis trials 
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
NARI NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
NARI NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
WHY: NEW YORK, NY - (NewMediaWire) - March 09, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical,... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
Bragar Eagel & Squire, P.C. Is Investigating Thoughtworks, Chemours, Methanex, and Inari Medical and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
NARI LOSS ALERT: ROSEN, A RESPECTED AND LEADING FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
NARI LOSS ALERT: ROSEN, A RESPECTED AND LEADING FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
WHY: NEW YORK, NY - (NewMediaWire) - March 07, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical,... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.